Xxera/openscience/retractions

Record #11629

Inactivation of PI(3)K p110delta breaks regulatory T-cell-mediated immune tolerance to cancer

Khaled Ali, Dalya R Soond, Roberto Piñeiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, Cheryl L Scudamore, Timothy Hancox, Heather Maecker, Lori Friedman, Martin Turner, Claus Okkenhaug, Bart Vanhaesebroeck

Journal

Publisher

Nature Publishing Group

Original paper date

Jun 11, 2014

Original DOI

10.1038/nature13444

Country

🇬🇧 United Kingdom · 🇺🇸 United States

Institution

UCL Cancer Institute, Paul O’Gorman Building, University College London, London · Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge · Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, London · Mary Lyon Centre, MRC Harwell, Harwell Science and Innovation Campus, Harwell · Piramed Pharma, Slough, Berkshire · Cancer Signaling and Translational Oncology, Genentech Inc, South San Francisco, California

Open access

No

Article type

Research Article

Broad categories

(BLS) Biology - Cancer (HSC) Medicine - Cardiovascular (HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Notes from Retraction Watch

Queen Mary University of London and General Medical Council investigated Thorsten Hagemann

Citation lifecycle

How this paper is being cited

Pre-retraction

102

Same day

1

Post-retraction

548

% post-retraction

121.5%

~56.0 citations/yr before retraction · ~52.5 citations/yr after

— citing papers

Who is still citing this work

Loading…